GlassScriptPhysician profile
Gledi Peco
NPI 1417454562
$7,596.25
in general payments reported to CMS, 2019-2025
11 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $6,711 · 2023: $105 · 2024: $306 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $2,540.93 | 2021-2022 | |
| Stryker Corporation | $2,310.27 | 2021-2025 | Augment Injectable, 7 X 23mm Citrelock Implant, Ortholoc 2 Lapifuse |
| Paragon 28, INC. | $2,183.51 | 2022 | |
| Treace Medical Concepts, INC. | $173.50 | 2024-2025 | |
| Acera Surgical, INC. | $161.53 | 2024 | Restrata Wound Matrix |
| Bone Support INC. | $67.04 | 2025 | Cerament G, Ceramentbone Void Filler |
| Axogen | $47.19 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Smith+Nephew, INC. | $43.17 | 2022-2023 | Collagenase Santyl, Grafix Pl, Oasis |
| Polynovo North America LLC | $40.13 | 2024 | Novosorb Btm |
| Solventum Corporation | $21.72 | 2024 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Advanced Oxygen Therapy INC. | $7.26 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gledi Peco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.